• Human CEACAM8/CD66b protein (Recombinant) (C-hFC) (STJP002061)

Human CEACAM8/CD66b protein (Recombinant) (C-hFC) (STJP002061)

SKU:
STJP002061

Current Stock:
Host: HEK293 cells
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Human CEACAM8/CD66b-C-hFC protein was developed from hek293 cells and has a target region of C-hFC. For use in research applications.
Formulation: Lyophilized from a 0.2 Mu m filtered solution of 20mM PB, 150mM NaCl, pH 7.4.
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: CEACAM8
Gene ID: 1088
Uniprot ID: CEAM8_HUMAN
Immunogen Region: Gln35-Ser319
Immunogen: Recombinant Human CEACAM8/CD66b Protein is produced by Mammalian expression system. The target protein is expressed with sequence (Gln35-Ser319) of human CEACAM8 (Accession #P31997) fused with a hFC tag at the C-terminus.
Post Translational Modifications Glycosylated.
Function Cell surface glycoprotein that plays a role in cell adhesion in a calcium-independent manner. Mediates heterophilic cell adhesion with other carcinoembryonic antigen-related cell adhesion molecules, such as CEACAM6. Heterophilic interaction with CEACAM8 occurs in activated neutrophils.
Protein Name Carcinoembryonic Antigen-Related Cell Adhesion Molecule 8
Cd67 Antigen
Carcinoembryonic Antigen Cgm6
Non-Specific Cross-Reacting Antigen Nca-95
Cd Antigen Cd66b
Database Links Reactome: R-HSA-1566977
Reactome: R-HSA-202733
Reactome: R-HSA-6798695
Cellular Localisation Cell Membrane
Lipid-Anchor
Gpi-Anchor
Cell Surface
Alternative Protein Names Carcinoembryonic Antigen-Related Cell Adhesion Molecule 8 protein
Cd67 Antigen protein
Carcinoembryonic Antigen Cgm6 protein
Non-Specific Cross-Reacting Antigen Nca-95 protein
Cd Antigen Cd66b protein
CEACAM8 protein
CGM6 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance